Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Blind, Randomized Controlled Clinical Trial of the Safety and Efficacy of Absorbable Hemostatic Fluid Gelatin for Surgical Hemostasis

NCT07830797 is registered in ClinicalTrials.gov with Medprin Regenerative Medical Technologies Co., Ltd. as lead sponsor.

NCT NCT07830797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07830797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Blind, Randomized Controlled Clinical Trial of the Safety and Efficacy of Absorbable Hemostatic Fluid Gelatin for Surgical Hemostasis
Lead sponsor
Medprin Regenerative Medical Technologies Co., Ltd.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 8, 2026
Completion date
August 31, 2027
Enrollment
324 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

surgical bleeding